Literature DB >> 1372295

Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis.

S U Sajjan1, J F Forstner.   

Abstract

In previous experiments, we have shown that isolates of Pseudomonas cepacia from sputa of patients with cystic fibrosis (CF), particularly those with severe lung infection, exhibited specific binding to purified respiratory or intestinal mucins (U. Sajjan, M. Corey, M. Karmali, and J. Forstner, J. Clin. Invest. 89:648-656, 1992). The present report describes the identification of the adhesin as a protein located on fimbriae of mucin-binding P. cepacia. From a total of 53 isolates available (from 22 patients with CF), we used three mucin-binding and three non-mucin-binding isolates for our experiments. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of crude P. cepacia homogenates was performed, the separated proteins were blotted onto nitrocellulose and overlaid with purified mucin, and mucin-binding components were detected with an antimucin antibody and then a second-antibody-alkaline phosphatase conjugate system. Only mucin-binding isolates exhibited a positively stained band at an Mr of 22,000. The 22-kDa protein was purified, and a polyclonal antibody specific for it was developed in rabbits. By electron microscopy and immunogold labelling, both the antibody and mucin (separately) were localized to pili present over the entire surface of the bacterial cells. Non-mucin-binding isolates did not have (or had very few) pili and did not stain with either mucin or the antibody to the 22-kDa protein. The purified 22-kDa protein and its antibody were each able to inhibit piliated P. cepacia binding to mucin. The amino acid composition of the 22-kDa protein was dissimilar to those of the major pilin proteins of Escherichia coli (type 1 pilus) and P. aeruginosa (PAK and PAO1 strains). Both the pili of P. aeruginosa PAK and PAO1 and antibodies to these pili failed to inhibit P. cepacia binding to mucin. Thus, P. cepacia adhesion to mucin is mediated by a pilin-associated 22-kDa protein which differs from epithelial-cell-binding pilin proteins of P. aeruginosa. We postulate that the 22-kDa adhesin may play a role in the virulence of P. cepacia lung infections of patients with CF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372295      PMCID: PMC257015          DOI: 10.1128/iai.60.4.1434-1440.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Subacute and acute endocarditis due to Pseudomonas cepacia in heroin addicts.

Authors:  E R Noriega; E Rubinstein; M S Simberkoff; J J Rahal
Journal:  Am J Med       Date:  1975-07       Impact factor: 4.965

2.  The putative 'link' glycopeptide associated with mucus glycoproteins. Composition and properties of preparations from the gastrointestinal tracts of several mammals.

Authors:  A M Roberton; M Mantle; R E Fahim; R D Specian; A Bennick; S Kawagishi; P Sherman; J F Forstner
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Radioimmunoassay of human intestinal goblet cell mucin. Investigation of mucus from different organs and species.

Authors:  R Qureshi; G G Forstner; J F Forstner
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

6.  Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.

Authors:  U S Sajjan; M Corey; M A Karmali; J F Forstner
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

7.  Mapping of the antigenic determinants of Pseudomonas aeruginosa PAK polar pili.

Authors:  T H Watts; P A Sastry; R S Hodges; W Paranchych
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

8.  Hyperadhesive mutant of type 1-fimbriated Escherichia coli associated with formation of FimH organelles (fimbriosomes).

Authors:  S N Abraham; J D Goguen; E H Beachey
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

9.  Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae.

Authors:  K A Krogfelt; H Bergmans; P Klemm
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

10.  Inhibition of pilus-mediated adhesion of Pseudomonas aeruginosa to human buccal epithelial cells by monoclonal antibodies directed against pili.

Authors:  P Doig; P A Sastry; R S Hodges; K K Lee; W Paranchych; R T Irvin
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

View more
  27 in total

Review 1.  Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

Authors:  J R Govan
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

2.  The level of expression of the minor pilin subunit, CooD, determines the number of CS1 pili assembled on the cell surface of Escherichia coli.

Authors:  H Sakellaris; V R Penumalli; J R Scott
Journal:  J Bacteriol       Date:  1999-03       Impact factor: 3.490

3.  Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.

Authors:  U Sajjan; G Thanassoulis; V Cherapanov; A Lu; C Sjolin; B Steer; Y J Wu; O D Rotstein; G Kent; C McKerlie; J Forstner; G P Downey
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Cable pili and the 22-kilodalton adhesin are required for Burkholderia cenocepacia binding to and transmigration across the squamous epithelium.

Authors:  Teresa A Urban; Joanna B Goldberg; Janet F Forstner; Umadevi S Sajjan
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

5.  Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis.

Authors:  E Mahenthiralingam; D A Simpson; D P Speert
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

Review 6.  New perspectives in understanding and management of the respiratory disease in cystic fibrosis.

Authors:  S Suter
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

7.  Role of a 22-kilodalton pilin protein in binding of Pseudomonas cepacia to buccal epithelial cells.

Authors:  U S Sajjan; J F Forstner
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

8.  Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia.

Authors:  I Jacques; J Derelle; M Weber; M Vidailhet
Journal:  Eur J Pediatr       Date:  1998-05       Impact factor: 3.183

Review 9.  Chronic rhinosinusitis pathogenesis.

Authors:  Whitney W Stevens; Robert J Lee; Robert P Schleimer; Noam A Cohen
Journal:  J Allergy Clin Immunol       Date:  2015-12       Impact factor: 10.793

Review 10.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.